Oxaliplatin and Docetaxel Followed by Cetuximab for Head and Neck Cancer
Status:
Terminated
Trial end date:
2012-04-01
Target enrollment:
Participant gender:
Summary
A study of Oxaliplatin and Docetaxel followed by Cetuximab for head and neck cancer patients
to determine their effect on the control and reduction of tumor size
Phase:
Phase 2
Details
Lead Sponsor:
University of Kansas University of Kansas Medical Center